Results 251 to 260 of about 32,347 (265)
Some of the next articles are maybe not open access.
Current Medical Research and Opinion, 2003
Managing invasive fungal infections often presents a challenge for clinicians in the treatment of immunocompromised patients. Two very different systemic antifungal agents, voriconazole and caspofungin, have recently been introduced into the market place. Voriconazole is a new triazole antifungal, while caspofungin is the first echinocandin antifungal.
openaire +2 more sources
Managing invasive fungal infections often presents a challenge for clinicians in the treatment of immunocompromised patients. Two very different systemic antifungal agents, voriconazole and caspofungin, have recently been introduced into the market place. Voriconazole is a new triazole antifungal, while caspofungin is the first echinocandin antifungal.
openaire +2 more sources
Cellular and Molecular Life Sciences, 2014
Fungal disease is an increasing problem in both agriculture and human health. Treatment of human fungal disease involves the use of chemical fungicides, which generally target the integrity of the fungal plasma membrane or cell wall. Chemical fungicides used for the treatment of plant disease, have more diverse mechanisms of action including inhibition
Brigitte M E, Hayes +4 more
openaire +2 more sources
Fungal disease is an increasing problem in both agriculture and human health. Treatment of human fungal disease involves the use of chemical fungicides, which generally target the integrity of the fungal plasma membrane or cell wall. Chemical fungicides used for the treatment of plant disease, have more diverse mechanisms of action including inhibition
Brigitte M E, Hayes +4 more
openaire +2 more sources
Leukemia Research
Voriconazole has been a standard antifungal prophylactic (AFP) agent for patients with acute myeloid leukemia (AML) during neutropenia. However, its use is complicated by side-effects including transaminase elevations, visual disturbances, and significant drug-drug interactions (DDIs).
Cameron J. Hunter +9 more
openaire +2 more sources
Voriconazole has been a standard antifungal prophylactic (AFP) agent for patients with acute myeloid leukemia (AML) during neutropenia. However, its use is complicated by side-effects including transaminase elevations, visual disturbances, and significant drug-drug interactions (DDIs).
Cameron J. Hunter +9 more
openaire +2 more sources
Evolution of antifungal drug tolerance in Candida albicans
2019Mestrado em Biomedicina ...
openaire +1 more source
Identification and Elimination of Antifungal Tolerance in Candida auris
Biomedicines, 2023Samira Rasouli Koohi +2 more
exaly
Tunicamycin Potentiates Antifungal Drug Tolerance via Aneuploidy in Candida albicans
MBio, 2021Feng Yang +2 more
exaly
Candida parapsilosis Sensu Stricto Antifungal Resistance Mechanisms and Associated Epidemiology
Journal of Fungi (Basel, Switzerland), 2023Iacopo Franconi +2 more
exaly